| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000020272 |
| Receipt No. | R000023403 |
| Scientific Title | Bioequivalence study of the consumption of plant-derived processed product with anti-obesity in healthy adults |
| Date of disclosure of the study information | 2016/01/20 |
| Last modified on | 2019/08/26 (Ver. 10) |
| Basic information | ||
| Public title | Bioequivalence study of the consumption of plant-derived processed product with anti-obesity in healthy adults | |
| Acronym | Bioequivalence study of plant-derived processed product in healthy adults. | |
| Scientific Title | Bioequivalence study of the consumption of plant-derived processed product with anti-obesity in healthy adults | |
| Scientific Title:Acronym | Bioequivalence study of plant-derived processed product in healthy adults. | |
| Region |
|
|
| Condition | |||
| Condition | Healthy subjects | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the bioequivalence of original product A-001and generic product A-002 |
| Basic objectives2 | Bio-equivalence |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | AUC0-8hr and Cmax of postprandial triglyceride |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Product code A-002(1day, 1time, 10g), washout(over 6days), product code A-001(1day, 1time, 10g) | |
| Interventions/Control_2 | Product code A-001(1day, 1time, 10g), washout(over 6days), product code A-002(1day, 1time, 10g) | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)BMI>=23.0and<30.0 kg/m2
2)Age>=35 and<65 years old 3)Person who provides inforrned consent by a document |
|||
| Key exclusion criteria | 1) individual with liver, kidney and heart disease, or disorder of respiration, endocrine, metabolism, nervous system, consciousness, or diabetes, or other diseases, 2) individual given surgery within 2 months before the trial, 3) medicine user for hyperglycaemia, lipidemia, or hypertension, 4) individual intakes supplements or the food for specific use of health authorized the government, 5) individual experienced unpleasant feeling during blood drawing, 6) individual donated 200 mL or more blood within 1 month before the trial, 7) heavy smoker (cigarettes>=21/day), 8) shiftworker, 9) individual plans bussiness trip for 10 consecutive days or more, 10) individual had allergy against any constituents in the test diet, 11) individual can not conform to record of daily diet for 6 days (3 days x 2 times), 12) individual cannot allow operator to consult his/her data of the past health check, 13) individual have already participated other clinical trial and will participate, 14) pregnant women or breast-feeding women, 15) individual who was judged ineligibles by clinician in this trial | |||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kao Corporation | ||||||
| Division name | Health Care Food Research Labs. | ||||||
| Zip code | 131-6501 | ||||||
| Address | 2-1-3 Bunka Sumida-ku Tokyo | ||||||
| TEL | 03-5630-7456 | ||||||
| shoji.kentaro@kao.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | New Drug Research Center, Inc. | ||||||
| Division name | Clinical Research Dept. | ||||||
| Zip code | 061-1405 | ||||||
| Address | 452-1 Toiso, Eniwa-shi, Hokkaido | ||||||
| TEL | 0123-34-0412 | ||||||
| Homepage URL | |||||||
| s-tomita@ndrcenter.co.jp | |||||||
| Sponsor | |
| Institute | New Drug Research Center, Inc. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kao Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | The Ethics Review Board of Miyawaki Orthopedic Hospital |
| Address | 3-1-6 Ariake-cho, Eniwa city, Hokkaido |
| Tel | 0123-33-4026 |
| d-kameda@mediffom.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 福原医院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | Unpublished due to the protocol including the intellectual property rights |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | works in progress | ||||||
| Number of participants that the trial has enrolled | 17 | ||||||
| Results | he result suggested that there was bioequivalence between test food and control food. |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | Healthy subjects |
||||||
| Participant flow | 20 participants completed and 17 subjects were incorporated into the analyses |
||||||
| Adverse events | No adverse effect related to the test diets reported |
||||||
| Outcome measures | AUC0-8hr and Cmax of postprandial triglyceride |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023403 |